Basic Information
Panomics is a private life science company focused on Parallel Quantitative Biology (PQB), a platform of reagents and products that enable multiplexed measurements of molecular events in a quantitative and scalable manner, such as intracellular pathway analysis, cell signaling, and gene expression profiling. Panomics has rapidly grown based on the value of QuantiGene and QuantiGene Plex, our proprietary bDNA technology used for gene expression analysis in cell assays, as well as our signal transduction and transcription factor assays. The company recently launched delivery X, a new siRNA delivery reagent for non-cytotoxic transfection of RNAi reagents into primary cell lines, the first in a series of biomolecule delivery products.